Welcome to the European Association for Cancer Research
Connecting cancer researchers together
Liquid Biopsies
Virtual Event, Worldwide : 18 - 19 November 2020
Scientific Programme
To download and print the programme, use the links below.
Listed times are in Central European Time (CET).
WELCOME TO DAY 1
Chair: Caroline Dive
Nickolas Papadopoulos Johns Hopkins University, USA
"Development of multi-analyte blood tests for the earlier detection of cancer"
Q&A: 14:25 - 14:45
Exhibitor Introductions
Gabriella Sozzi Istituto Nazionale Tumori, Italy
"Biomarkers for early detection of lung cancer: the role of microRNAs"
Q&A: 15:10 - 15:30
5-minute break
INDUSTRY SYMPOSIUM - Thermo Fisher Scientific
Winand N.M. Dinjens University Medical Center Rotterdam, Netherlands
"4 year experience of cfDNA NGS analysis: is it ready for a clinical setting?"
Break
Coffee & stretching
Chris Abbosh UCL Cancer Institute, UK
"The clinical utility of ctDNA in minimal residual disease and the emergence of metastatic disease"
Q&A: 16:35 - 16:55
5-minute break
Riccardo Masina CRUK Cambridge Institute, UK
Proffered Paper 1: "Serial assessment of circulating tumour DNA in a phase 1b trial of ER positive metastatic breast cancer patients by multiple NGS-based approaches"
Q&A: 17:10 - 17:20
Francesca Chemi CRUK Manchester Institute, UK
Proffered Paper 2: "Investigating SCLC Acquired Chemotherapy Resistance Through Liquid Biopsy DNA Methylation Profiling"
Q&A: 17:30 - 17:40
5-minute break
Muhammed Murtaza University of Wisconsin, USA
"Monitoring treatment response in cancer patients using circulating tumor DNA analysis"
Q&A: 18:05 - 18:25
5-minute break
Poster Spotlights
3 top abstracts presented as 3 minute flash talks
END OF DAY 1 SUMMARY
Virtual Poster Discussion Session
WELCOME TO DAY 2
Chair: Evi Lianidou
Alberto Bardelli University of Torino, Italy
"Tracking and targeting colorectal cancer evolution"
Q&A: 14:25 - 14:45
5-minute break
Alicia-Marie Conway CRUK Manchester Institute, UK
Proffered Paper 3: "Identifying Liquid biomarkers to detect tissue of origin and direct therapy in Cancers of Unknown Primary: taking the ‘U’ out of ‘CUP’"
Q&A: 15:00 - 15:10
Jonine Figueroa University of Edinburgh, UK
Proffered Paper 4: "Circulating tumor DNA is readily detectable in plasma samples among Ghanaian breast cancer patients supporting liquid biopsy studies in sub-Saharan Africa"
Q&A: 15:20 - 15:30
5-minute break
INDUSTRY SYMPOSIUM - Roche
Aadel Chaudhuri Washington University Medical Center, USA
"ctDNA MRD detection and personalized oncogenomic analysis in oligometastatic colorectal cancer from plasma and urine"
Break
Coffee & stretching
Ellen Heitzer Medical University of Graz, Austria
"Assessment of ctDNA workflows for clinical decision making"
Q&A: 16:35 - 16:55
5-minute break
Giulia Siravegna Mass General Cancer Center, USA
"Circulating DNA analysis to uncover minimal residual disease and predict drug response in gastrointestinal cancer patients"
Q&A: 17:20 - 17:40
5-minute break
DISCUSSION FORUM
Caroline Dive, Carlos Caldas, Evi Lianidou
END OF DAY 2 SUMMARY
Key dates
Abstract submission deadline:
29 September 2020
Registration deadline:
17 November 2020
